Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$433K Sell
1,195
-4
-0.3% -$1.37K 0.16% 188
2026
Q1
$422K Sell
1,199
-312
-21% -$111K 0.21% 180
2025
Q4
$495K Buy
1,511
+20
+1% +$6.34K 0.25% 131
2025
Q3
$421K Buy
+1,491
New +$432K 0.22% 188

Other funds holding AMGN

Optimize Financial's AMGN Position: Q2 2026 in Review

Optimize Financial reduced its Amgen (AMGN) stake by 0.33% in Q2 2026, selling an estimated $1.37K and leaving 1,195 shares worth $433K. The position accounts for 0.16% of the portfolio, ranked #188.

Optimize Financial first reported a position in AMGN in Q3 2025 and has held it in 4 quarters since. The position peaked at $495K in Q4 2025. 3,164 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Optimize Financial held 1,195 shares of Amgen worth $433K as of Q2 2026.
  • Optimize Financial sold 4 Amgen shares in Q2 2026, an estimated $1.37K.
  • Amgen made up 0.16% of Optimize Financial's portfolio in Q2 2026, its #188 holding.
  • Optimize Financial first reported a position in Amgen in Q3 2025 and has held it in 4 quarters since.
  • Optimize Financial's Amgen position peaked at $495K in Q4 2025.
  • 3,164 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Optimize Financial's 13F filing for Q2 2026, filed 27 Aug 2026.